未名医药 (002581.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(未名医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年中报2020年一季报2019年年报2019年三季报2019年中报2019年一季报2018年年报2018年三季报2018年中报2018年一季报
主要指标:
 营业收入(元) 135,955,018.58101,885,863.74610,638,764.31434,430,783.68299,601,012.35126,174,347.60664,593,783.42492,895,743.78293,779,782.55147,149,643.83
 营业利润(元) -102,271,341.75-44,780,480.7653,709,665.9060,776,389.2035,111,553.73-7,290,227.64-81,407,992.5627,720,409.329,883,015.2788,575,708.38
 利润总额(元) -102,045,018.78-45,208,781.3752,547,248.1360,306,263.0634,677,471.15-7,610,975.38-83,175,449.7327,270,155.2310,490,092.9388,653,370.67
 净利润(元) -87,597,503.04-48,667,600.6251,630,763.7357,539,925.3331,533,829.73-9,779,289.94-92,556,821.4911,941,532.113,828,507.0882,202,345.01
 归属于母公司股东的净利润(元) -92,352,623.14-62,820,716.4943,778,120.6449,319,311.2925,655,258.83-12,926,715.18-95,789,054.1212,592,914.265,594,035.7682,372,632.77
盈利能力:
 销售毛利率(%) 84.3083.6387.8587.5987.6287.2085.1784.1582.7983.71
 销售净利率(%) -64.43-47.778.4613.2410.53-7.75-13.932.421.3055.86
 净资产收益率(%) -3.69-2.481.701.740.91-0.45----
 总资产报酬率ROA(%) -2.77-0.971.511.441.12-0.11----
 投入资本回报率ROIC(%) -2.97-1.981.211.280.66-0.34-2.470.320.142.07
营运能力:
 存货周转率(次) 0.320.291.371.060.720.32----
 应收账款周转率(次) 0.320.231.400.900.620.28----
 总资产周转率(次) 0.040.030.160.110.070.03----
偿债能力:
 资产负债率(%) 29.7728.6529.4925.6829.0729.0834.2331.3632.0231.12
 股东权益比率(%) 67.7468.7668.4172.4369.1769.2164.2667.2166.5967.47
 已获利息倍数(倍) -153.09-3.669.85-33.373.91-1.40-0.731.931.5911.80
 流动比率 5.737.057.659.197.459.154.485.404.865.17
 速动比率 5.326.537.138.657.118.754.365.244.715.04
发展能力:
 营业收入增长率(%) -54.62-19.25-9.37-11.861.98-14.25-42.83-35.26-44.60-45.69
 营业利润增长率(%) -391.28-514.25159.88119.25255.27-108.23-117.44-91.00-95.12-3.50
 税后利润增长率(%) -459.98-385.98142.55291.64358.62-115.69-124.66-95.38-96.846.63
 净资产增长率(%) -20.38-15.88-14.40-2.06-2.64-6.50-3.354.698.2115.45
 总资产增长率(%) -18.70-15.34-19.56-9.12-6.28-8.847.5015.5052.3659.97

前瞻产业研究院